Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942002000100006
Brazilian Journal of Anesthesiology
Scientific Article

Eficácia da solução de cloreto de sódio a 7,5% com e sem dextran 70 a 6% na preservação da função renal de cães hipovolêmicos submetidos à isquemia-reperfusão

Efficacy of 7.5% hypertonic sodium chloride, with and without 6% dextran 70, in renal function preservation of hypovolemic dogs submitted to ischemia-reperfusion

Geraldo Rolim Rodrigues Júnior; José Luiz Gomes do Amaral; Yara Marcondes Machado Castiglia; Mariangela Esther Alencar Marques

Downloads: 0
Views: 1029

Resumo

JUSTIFICATIVA E OBJETIVOS: As soluções hipertônicas de cloreto de sódio, associadas ou não a colóides hiperoncóticos, podem ser eficazes em proteger o rim em situações de hipovolemia. O objetivo deste estudo foi verificar, em cães, o real benefício dessas soluções sobre a função renal, em vigência de hipovolemia e isquemia do órgão. MÉTODO: Em 24 cães, anestesiados com pentobarbital sódico, submetidos à nefrectomia direita e à expansão volêmica com solução de Ringer (1 ml.kg-1.min-1), foram observadas possíveis alterações renais morfo-funcionais após hemorragia de 20 ml.kg-1 e trinta minutos de total isquemia renal esquerda, com posterior reperfusão, além da repercussão renal da administração de soluções de cloreto de sódio 7,5% (SH) e esta em dextran 70 a 6% (SHD). Atributos estudados: FC, PAM, pressão de veia cava inferior, fluxo sangüíneo renal, resistência vascular renal, hematócrito, Na+, K+, osmolaridade plasmática, PaO2, PaCO2 e pH, depuração (para-aminohipurato de sódio - PAH-1, creatinina, osmolar, água livre, Na+, K+), fração de filtração, volume e osmolaridade urinários, excreções urinárias e fracionárias de Na+ e K+ e exame histopatológico do rim. Os atributos foram estudados em três grupos (G1, G2 e G3) e em cinco momentos. RESULTADOS: Houve elevação estatisticamente significativa da pressão arterial média em G2 e G3, da resistência vascular renal em G1, do fluxo sangüíneo renal e da depuração de PAH em G3, da excreção fracionária de Na+ em G2 e G3, das depurações de creatinina, osmolar, de água livre e de Na+ e K+, da excreção urinária de Na+ e K+ e do volume urinário em G3. CONCLUSÕES: A SHD administrada 15 minutos após hemorragia moderada e 30 minutos antes de insulto isquêmico de 30 minutos foi eficiente em proteger o rim de cães das repercussões da isquemia-reperfusão. Não foi constatada alteração histopatológica renal à microscopia óptica.

Palavras-chave

ANIMAL, VOLEMIA, VOLEMIA, VOLEMIA

Abstract

BACKGROUND AND OBJECTIVES: Sodium chloride hypertonic solutions, with or without hyperoncotic colloids, may be effective in protecting kidney against hypovolemia. This experiment aimed at evaluating, in dogs, the real benefit of these solutions on renal function in the presence of hypovolemia and ischemia. METHODS: Experiments were performed in 24 mixed-breed dogs anesthetized with sodium pentobarbital, submitted to right nephrectomy and volume expansion with Ringer’s solution (1 ml.kg-1.min-1). Renal morphological and physiological changes were studied after 20 ml.kg-1 hemorrhage and 30 min of total left renal ischemia followed by reperfusion, in addition to renal repercussion of 7.5% NaCl (HS) and 7.5% NaCl in 6% dextran 70 (HSD). The following parameters were studied: HR, MBP, inferior vena cava pressure, renal blood flow, renal vascular resistance, hematocrit, Na+, K+, plasma osmolarity, PaO2, PaCO2 and pH; clearance (para-aminohipuric acid - PAH-1, creatinine, free water, osmolar, Na+ and K+), filtration fraction, urine output and osmolarity, sodium and potassium urine and fractionated excretions; rectal temperature; and kidney histopathology. Atributes where studied in five moments in three groups (G1, G2 and G3). RESULTS: There has been a statistically significant increase in mean blood pressure in G2 and G3. RVR was higher in G1; RBF and PAH clearance were higher in G3; Na+ fractionated excretion was increased in G2 and G3; creatinine, free water, osmolar, Na+ and K+ clearances, diuresis, and urinary excretions of Na+ and K+ were higher in G3. CONCLUSIONS: HSD infusion 15 min after mild hemorrhage and 30 min before ischemia was effective in protecting kidney of dogs from ischemia-reperfusion repercussions. There have been no histopathologic changes under optical microscopy.

Keywords

ANIMAL, VOLEMIA, VOLEMIA, VOLEMIA

Referencias

Brown JM, Grosso MA, Moore EE. Hypertonic saline and dextran: impact on cardiac function in the isolated rat heart. J Trauma. 1990;30:646-651.

Stanford GG, Patterson CR, Payne L. Hypertonic saline resuscitation in a porcine model of severe hemorrhagic shock. Arch Surg. 1989;124:733-736.

Kramer GC, Elgjo GI, De Figueiredo LFP. Hypertonic-hyperoncotic solutions. Baillière’s Clin Anaesth. 1997;ll:143-161.

Módolo NSP, Castiglia YMM, Ganem EM. Acute renal ischemia model in dogs: effects of metoprolol. Ren Fail. 2001;23:1-10.

Szold A, Pizov R, Segal E. The effect of tidal volume and intravascular volume state on systolic pressure variation in ventilated dogs. Intensive Care Med. 1989;15:368-371.

Velasco IT, Pontieri V, Rocha e Silva M. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol. 1980;239:h664-h673.

Wolf MB. Plasma volume dynamics after hypertonic fluid infusing in nephrectomized dog. Am J Physiol. 1971;221:1392-1395.

Halvorsen L, Günther RA, Dubick MA. Dose response of hypertonic saline dextran solutions. J Trauma. 1991;31:785-794.

Traverso LW, Bellamy RF, Hollenbach SJ. Hypertonic sodium cloride solutions: effect on hemodynamics and survival after hemorrhage in swine. J Trauma. 1987;27:32-39.

Nguyen TT, Zwischenberger JB, Watson WC. Hypertonic acetate dextran achieves high-flow-low-pressure resuscitation of hemorragic shock. J Trauma. 1995;38:602-608.

Velasco IT, Rocha e Silva M, Oliveira MA. Hypertonic and hyperoncotic resuscitation from severe hemorragic shock in dogs: a comparative study. Crit Care Med. 1989;17:261-264.

Summary JT, Dubick MA, Zaucha GM. Acute and subacute toxicity of 7.5% hypertonic saline/6% dextran (HSD) in dogs: serum immunoglobulin and complement responses. J Appl Toxicol. 1992;12:261-266.

Dubick MA, Wade CE. A review of the efficacy and safety of 7.5% NaCl/6% dextran 70% in experimental animals and in humans. J Trauma. 1994;36:323-330.

Mazzoni M, Warnke KC, Arfors K. Capillary hemodynamics hemorrhagic shock and reperfusion: in vivo and model analysis. Am J Physiol. 1994;267:h1928-h1935.

Mazzoni M, Borgstrom P, Intaglietta M. Capillary narrowing in hemorragic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock. 1990;31:407-418.

Behrman SW, Fabian TC, Kudsk KA. Microcirculatory flow changes after initial resuscitation of hemorrhagic shock with 7.5% hypertonic saline -6% dextran 70. J Trauma. 1991;31:589-560.

Soonden JL, Gunther RA, Dubick MA. Comparison of 7.5% NaCl/6% dextran 70 resuscitation of hemorrhage between euhydrated sheep. Shock. 1995;3:63-68.

Rocha e Silva M. Hypertonic saline resuscitation: a new concept. Baillière’s Clin Anaesth. 1997;ll:127-142.

Sztark F, Gékiere JP, Dabadie A. Effects hémodynamiques des solution salées hypertoniques. Ann Fr Anesth Réanim. 1997;16:282-291.

Vlahakes GJ, Giamber SR, Rothaus KO. Hyperosmotic mannitol and collateral blood flow to ischemic to ischemic myocardium. J Surg Res. 1989;47:438-446.

Kreimeier U, Bruckner UB, Niemczyk S. Hyperosmotic saline dextran for resuscitation from traumatic-hemorragic hypotension: effect on regional blood flow. Circ Shock. 1990;32:83-99.

Prough DS. Controverses in perioperative fluid management [IARS - Review Course Lectures]. Anesth Analg. 1994:16-24.

Sutin KM, Ruskin KJ, Kaufman BS. Intravenous fluid therapy on neurological injury. Crit Care Clin. 1992;8:367-408.

Matthew CB. Treatment of hyperthermia and dehydration with hypertonic saline in dextran. Shock. 1994;2:216-221.

Huang PP, Stucky FS, Dimicky AR. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg. 1995;221:543-557.

Richards AM, Nichols MG, Ikram H. Renal haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985:545-549.

English TP, Weber CJ, Holcroft JW. The role of ANF in the diureses following hypertonic resuscitation. Circ Shock. 1989;27:346.

Albrecht MD, Schroth M, Fahnle M. Effects of hypertonic-hyperoncotic infusion on the human atrial natriuretic factor in a standardized trial. Shock. 1995;3:152-156.

Cox AT, Ho HS, Gunther RA. High level of arginine vasopressin and 7.5% NaCl/6% dextran-70 solution: cardiovascular and renal effects. Shock. 1994;1:372-376.

Wade CE, Hannon JP, Bossone CA. Neuroendocrine responses to hypertonic saline/dextran resuscitation following hemorrhage. Circ Shock. 1991;35:37-43.

Shackford SR, Norton CH, Todd MM. Renal, cerebral, and pulmonary effects of hypertonic resuscitation in a porcine model of hemorrhagic shock. Surgery. 1988;104:553-560.

Vincent JL. Fluids for resuscitation. Br J Anaesth. 1991;67:185-193.

Wade CE, Tillman FJ, Loveday JA. Effect of dehydratation on cardiovascular response and eletrolytes after hypertonic saline/dextran treatment for moderate hemorrhage. Ann Emerg Med. 1992;21:113-119.

Moon PF, Kramer GC. Hypertonic saline-dextran resuscitation from hemorrhage shock induces transient mixed acidosis. Crit Care Med. 1995;23:323-331.

Finn WF. Prevention of ischemic injury in renal transplantation. Kidney Int. 1990;37:171-182.

Honda N, Hishida A. Pathophysiology of experimental non-oliguric acute renal failure. Kidney Int. 1993;43:513-521.

5dd59a240e8825060cc8fca6 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections